Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alemtuzumab Induced Thyroid Disease in Multiple Sclerosis: A Review and Approach to Management
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
Volume 42, Issue 05, Pages 284-291
Publisher
Cambridge University Press (CUP)
Online
2015-05-20
DOI
10.1017/cjn.2015.48
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Graves' disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?
- (2014) Anthony P. Weetman CLINICAL ENDOCRINOLOGY
- Hyperthyroidism and other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinoloigists
- (2013) Rebecca Bahn et al. Endocrine Practice
- Clinical Utility of TSH Receptor Antibodies
- (2013) Giuseppe Barbesino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis
- (2013) Gilbert H. Daniels et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Message from the Editors to our Reviewers
- (2013) R. A. Gross et al. NEUROLOGY
- TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis
- (2012) R. Tozzoli et al. AUTOIMMUNITY REVIEWS
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association
- (2012) Jeffrey Garber et al. Endocrine Practice
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Subacute, Silent, and Postpartum Thyroiditis
- (2012) Mary H. Samuels MEDICAL CLINICS OF NORTH AMERICA
- The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data
- (2012) Ruth Ann Marrie et al. NEUROEPIDEMIOLOGY
- Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort
- (2011) M. Cossburn et al. NEUROLOGY
- Graves' Ophthalmopathy
- (2010) Rebecca S. Bahn NEW ENGLAND JOURNAL OF MEDICINE
- The Bethesda System for Reporting Thyroid Cytopathology
- (2009) Edmund S. Cibas et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started